# FDA Inspection 1254130 - Nivagen Pharmaceuticals Inc - October 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/nivagen-pharmaceuticals-inc/d1d3e24f-bdd7-4cbc-a434-040262a1caf4
Source feed: FDA_Inspections

> FDA Inspection 1254130 for Nivagen Pharmaceuticals Inc on October 23, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254130
- Company Name: Nivagen Pharmaceuticals Inc
- Inspection Date: 2024-10-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1254130 - 2024-10-23](https://www.keypedia.com/records/fda_inspections/nivagen-pharmaceuticals-inc/9b474578-996e-44c8-b740-fb125da1ae82)

Company: https://www.keypedia.com/companies/nivagen-pharmaceuticals-inc/3eba9a8d-d560-49ef-956e-aa59eea20360

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c